UniversityCagliari, OspPed Microcitemico, Cagliari
Cagliari, CAGLIARI, 09123, Italy
NCT Number: NCT06889727
Recent advances in the management of thalassemia have significantly improved life expectancy and quality of life of patients with this hemoglobinopathy, with a consequent increase in their reproductive potential and desire to have children.Since an initial report of a successful pregnancy in a woman with thalassemia major by Walker in 1969, hundreds of pregnancies have been reported so far, highlighting that women carefully managed in the preconception phase usually carry out a successful gestation and labor, both in case of spontaneous conception and assisted reproductive techniques.
Looking for future studies?
Notify Me18 year and older
Female
Observational
Cagliari, CAGLIARI, 09123, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 15 YEARS
To evaluate the number of pregnancies in women with beta thalassemia followed in Italian centres and how the increase in the average age of the thalassemia population impact on the number of new pregnancies over time
Time frame: 15 YEARS
many pregnancies occurred spontaneously
Time frame: 15 YEARS
number of pregnancies after hormonal stimulation
Time frame: 15 YEARS
To evaluate the likelihood of miscarriage
Time frame: 15 YEARS
To evaluate foetal death
Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia
Other
Pregnancy and Childbirth in Women with Thalassemia Yesterday and Today: a Multicentre Observational Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01758042
AL Amyloidosis, Acute Lymphoblastic Leukemia (ALL)
Boston, Massachusetts, United States
View Trial DetailsNCT01911871
Anemia, Anemia, Hemolytic
Paris, France
View Trial DetailsNCT07023029
Anemia, Anemia, Hemolytic
Baltimore, Maryland, United States
View Trial DetailsNCT06581627
Anemia, Anemia, Hemolytic
Beijing, Beijing Municipality, China
View Trial Details